about
Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccinesInhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance.Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Peripheral T-cell tolerance defined through transgenic mouse studies.Nematode-derived proteins suppress proliferation and cytokine production of antigen-specific T cells via induction of cell death.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.Recipient B cells are not required for graft-versus-host disease induction.B lymphocytes as antigen-presenting cell-based genetic vaccines.Targeting Dendritic Cells in vivo for Cancer Therapy.Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies.B-cell cross-presentation of autologous antigen precipitates diabetes.Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.Therapeutic lymphoma vaccines: importance of T-cell immunity.IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.Design and development of synthetic peptide vaccines: past, present and future.Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cellsDeveloping idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes.Regulation of costimulatory signal in maternal-fetal immune tolerance.Cancer vaccines. Any future?Golgi phosphoprotein 2 in physiology and in diseases.Efficient Culture of Human Naive and Memory B Cells for Use as APCs.Antigen-specific impairment of adoptive T-cell therapy against cancer: players, mechanisms, solutions and a hypothesis.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.Development of Peptide Vaccines in Dengue.B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell responseAbortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
P2860
Q27003955-0ABE252D-F10A-48A6-B7AC-52D555DA9D79Q33560416-F0C4D80E-D92F-4D15-94B3-A4DF1E4E18D7Q33713257-D0B0088B-C122-4DEB-A861-D57C9C63857EQ33765164-DFB8A65C-2DD2-4CC4-862F-67A356377885Q33857971-EB407EBB-8602-4898-BECA-0AD833465461Q34107796-59A51292-B57E-48FC-B542-BA75B77E70B5Q34109382-86638F82-FDF7-4660-9C0A-2E52A1DA5305Q34193042-43B09273-DAAC-4AB8-A567-4D00FE877854Q34825118-C4A110C0-2B99-45B6-BE7A-C581367F1ED4Q34898280-DB1E9DEA-2CBE-4EFA-B665-0B8628B2914DQ35104223-61CB57F8-0EDD-4EBA-8CE3-DC6C510DD39EQ35826422-7A8F968F-7C83-41DB-B130-EF4CE2DE121AQ35928270-D2B6FAF8-035F-4FA2-8BB1-D2FD92361E4FQ36001633-5228FE92-B68B-4517-8CA1-41C937EE08ADQ36245106-66AEDDD8-BB7C-431F-B491-27BC122CFB7AQ36287976-AC935CDA-8CF6-4EE9-BD64-EAF3A2709100Q36339548-BF075909-725E-4B92-94F3-ED062299A18CQ36526337-68FBA8F1-3C00-447E-8968-7512B957CCBFQ36530231-F4217FB8-40C9-4D99-AF73-866FC3AA1480Q36540470-EF8EBD85-00B3-42A4-BA94-1A6367578286Q36775969-CECE4A86-C95D-4FD2-A8D3-8635D913F441Q36897408-26C114B1-0884-4E5E-8C46-68CAB91D1331Q36899093-729C0109-22A6-4BEE-8DF6-4B842EEADA62Q37066662-476E83AB-0C4F-4059-AB8F-70E3689E2D77Q37142202-E801E00D-2A1A-494E-94F8-74CA4B3A9303Q37324329-43E6E32B-07C1-425B-8416-8E0F658F3F17Q37403114-0234D9C2-6A7F-439C-8EFA-DA09ACC90111Q37440696-66FF0D0C-D2EE-4BA9-BF8C-90D80E32563BQ37621601-B31B8FA4-3513-49CE-AEA3-58551754B3D8Q37833142-AD4B59DE-5E13-4C8E-867F-42F789BD12EEQ37885282-165E03DB-D8B1-49A3-B1BF-6176CBF75C40Q38041690-4FD8B382-CEE9-45B4-87B3-84974032C0F7Q38732881-F153B47E-CC80-4AAD-BD5F-B3333382E08FQ38869740-E40AE341-1B21-447E-99E3-9210C470CDC7Q39084950-C38A958F-ADBB-462E-843B-5255B05A1308Q39603444-A75B7BA1-30B8-4437-B7F4-340371B55DB4Q40038715-F0B1054C-CFB7-49F1-9723-88F0B51F5343Q40483578-25B4DA10-1EA5-4863-911A-850973D7CC5AQ42543764-84296311-0AF3-4EEF-A245-EEEE5FA4578FQ44577092-C995AF2F-A1A6-4C35-87EE-85EECA1E7203
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
B cells directly tolerize CD8(+) T cells.
@ast
B cells directly tolerize CD8(+) T cells.
@en
type
label
B cells directly tolerize CD8(+) T cells.
@ast
B cells directly tolerize CD8(+) T cells.
@en
prefLabel
B cells directly tolerize CD8(+) T cells.
@ast
B cells directly tolerize CD8(+) T cells.
@en
P2093
P2860
P356
P1476
B cells directly tolerize CD8(+) T cells.
@en
P2093
P2860
P304
P356
10.1084/JEM.188.11.1977
P407
P577
1998-12-01T00:00:00Z